AZD8931, an Equipotent, Reversible Inhibitor of Signaling by Epidermal Growth Factor Receptor, ERBB2 (HER2), and ERBB3: A Unique Agent for Simultaneous ERBB Receptor Blockade in Cancer
HICKINSON, D. Mark, KLINOWSKA, Teresa, MILLS, Elizabeth, GROSIOS, Konstantina, SMITH, Paul, BARLAAM, Bernard, WILKINSON, Robert W, OGILVIE, Donald, SPEAKE, Georgina, VINCENT, John, TRIGWELL, Cath, ANDERTON, Judith, BECK, Sarah, MARSHALL, Gayle, DAVENPORT, Sara, CALLIS, Rowena
Published in Clinical cancer research (15.02.2010)
Published in Clinical cancer research (15.02.2010)
Get full text
Journal Article
Preclinical anticancer activity of the potent, oral Src inhibitor AZD0530
Green, Tim P., Fennell, Mike, Whittaker, Robin, Curwen, Jon, Jacobs, Vivien, Allen, Jack, Logie, Armelle, Hargreaves, Judith, Hickinson, D. Mark, Wilkinson, Robert W., Elvin, Paul, Boyer, Brigitte, Carragher, Neil, Plé, Patrick A., Bermingham, Alun, Holdgate, Geoffrey A., Ward, Walter H.J., Hennequin, Laurent F., Davies, Barry R., Costello, Gerard F.
Published in Molecular oncology (01.06.2009)
Published in Molecular oncology (01.06.2009)
Get full text
Journal Article
Epidermal growth factor receptor tyrosine kinase inhibitors: similar but different?
Rukazenkov, Yuri, Speake, Georgina, Marshall, Gayle, Anderton, Judith, Davies, Barry R, Wilkinson, Robert W, Mark Hickinson, D, Swaisland, Alan
Published in Anti-cancer drugs (01.11.2009)
Published in Anti-cancer drugs (01.11.2009)
Get more information
Journal Article
Discovery of AZD8931, an Equipotent, Reversible Inhibitor of Signaling by EGFR, HER2, and HER3 Receptors
Barlaam, Bernard, Anderton, Judith, Ballard, Peter, Bradbury, Robert H, Hennequin, Laurent F. A, Hickinson, D. Mark, Kettle, Jason G, Kirk, George, Klinowska, Teresa, Lambert-van der Brempt, Christine, Trigwell, Cath, Vincent, John, Ogilvie, Donald
Published in ACS medicinal chemistry letters (08.08.2013)
Published in ACS medicinal chemistry letters (08.08.2013)
Get full text
Journal Article
Vandetanib inhibits both VEGFR-2 and EGFR signalling at clinically relevant drug levels in preclinical models of human cancer
BRAVE, Sandra R, ODEDRA, Rajesh, WAINWRIGHT, Anna, LOVICK, Susan C, MARK HICKINSON, D, WILKINSON, Robert W, BARRY, Simon T, SPEAKE, Georgina, RYAN, Anderson J, JAMES, Neil H, SMITH, NeilR, MARSHALL, Gayle B, ACHESON, Kerry L, BAKER, Dawn, HOWARD, Zoe, AY JACKSON, Lyns, RATCLIFFE, Kirsty
Published in International journal of oncology (01.07.2011)
Published in International journal of oncology (01.07.2011)
Get full text
Journal Article
5-Substituted 4-anilinoquinazolines as potent, selective and orally active inhibitors of erbB2 receptor tyrosine kinase
Ballard, Peter, Bradbury, Robert H., Hennequin, Laurent F.A., Hickinson, D. Mark, Johnson, Paul D., Kettle, Jason G., Klinowska, Teresa, Morgentin, Remy, Ogilvie, Donald J., Olivier, Annie
Published in Bioorganic & medicinal chemistry letters (01.10.2005)
Published in Bioorganic & medicinal chemistry letters (01.10.2005)
Get full text
Journal Article
Neutral 5-substituted 4-anilinoquinazolines as potent, orally active inhibitors of erbB2 receptor tyrosine kinase
Ballard, Peter, Barlaam, Bernard C., Bradbury, Robert H., Dishington, Allan, Hennequin, Laurent F.A., Hickinson, D. Mark, Hollingsworth, Ian M., Kettle, Jason G., Klinowska, Teresa, Ogilvie, Donald J., Pearson, Stuart E., Scott, James S., Suleman, Abid, Whittaker, Robin, Williams, Emma J., Wood, Robin, Wright, Lindsay
Published in Bioorganic & medicinal chemistry (15.11.2007)
Published in Bioorganic & medicinal chemistry (15.11.2007)
Get full text
Journal Article
Novel 3-alkoxy-1H-pyrazolo[3,4-d]pyrimidines as EGFR and erbB2 receptor tyrosine kinase inhibitors
DUCRAY, Richard, BALLARD, Peter, BARLAAM, Bernard C, HICKINSON, Mark D, KETTLE, Jason G, OGILVIE, Donald J, TRIGWELL, Catherine B
Published in Bioorganic & medicinal chemistry (01.02.2008)
Published in Bioorganic & medicinal chemistry (01.02.2008)
Get full text
Journal Article
Src Family Kinase Inhibitor Saracatinib (AZD0530) Impairs Oxaliplatin Uptake in Colorectal Cancer Cells and Blocks Organic Cation Transporters
MORROW, Christopher J, GHATTAS, Mohammad, SMITH, Christopher, BÖNISCH, Heinz, BRYCE, Richard A, HICKINSON, D. Mark, GREEN, Tim P, DIVE, Caroline
Published in Cancer research (Chicago, Ill.) (15.07.2010)
Published in Cancer research (Chicago, Ill.) (15.07.2010)
Get full text
Journal Article
A new series of neutral 5-substituted 4-anilinoquinazolines as potent, orally active inhibitors of erbB2 receptor tyrosine kinase
Barlaam, Bernard, Ballard, Peter, Bradbury, Robert H., Ducray, Richard, Germain, Hervé, Hickinson, D. Mark, Hudson, Kevin, Kettle, Jason G., Klinowska, Teresa, Magnien, Françoise, Ogilvie, Donald J., Olivier, Annie, Pearson, Stuart E., Scott, James S., Suleman, Abid, Trigwell, Cath B., Vautier, Michel, Whittaker, Robin D., Wood, Robin
Published in Bioorganic & medicinal chemistry (15.01.2008)
Published in Bioorganic & medicinal chemistry (15.01.2008)
Get full text
Journal Article
Novel 3-alkoxy-1 H-pyrazolo[3,4- d]pyrimidines as EGFR and erbB2 receptor tyrosine kinase inhibitors
Ducray, Richard, Ballard, Peter, Barlaam, Bernard C., Hickinson, Mark D., Kettle, Jason G., Ogilvie, Donald J., Trigwell, Catherine B.
Published in Bioorganic & medicinal chemistry letters (2008)
Published in Bioorganic & medicinal chemistry letters (2008)
Get full text
Journal Article
ChemInform Abstract: Novel 3-Alkoxy-1H-pyrazolo[3,4-d]pyrimidines as EGFR and erbB2 Receptor Tyrosine Kinase Inhibitors
Ducray, Richard, Ballard, Peter, Barlaam, Bernard C., Hickinson, Mark D., Kettle, Jason G., Ogilvie, Donald J., Trigwell, Catherine B.
Published in ChemInform (01.07.2008)
Published in ChemInform (01.07.2008)
Get full text
Journal Article